Gutjahr, A., Papagno, L., Vernejoul, F., Lioux, T., Jospin, F., Chanut, B., . . . Paul, S. (2020). New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses. Elsevier.
Chicago Style (17th ed.) CitationGutjahr, Alice, et al. New Chimeric TLR7/NOD2 Agonist Is a Potent Adjuvant to Induce Mucosal Immune Responses. Elsevier, 2020.
MLA (9th ed.) CitationGutjahr, Alice, et al. New Chimeric TLR7/NOD2 Agonist Is a Potent Adjuvant to Induce Mucosal Immune Responses. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.